Smithfield Trust’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.83M | Buy |
9,591
+159
| +2% | +$161K | 0.38% | 49 |
|
|
2025
Q4 | $10.1M | Buy |
9,432
+301
| +3% | +$288K | 0.45% | 43 |
|
|
2025
Q3 | $6.97M | Sell |
9,131
-3
| -0% | -$2.23K | 0.31% | 54 |
|
|
2025
Q2 | $7.12M | Hold |
9,134
| – | – | 0.34% | 51 |
|
|
2025
Q1 | $7.54M | Sell |
9,134
-94
| -1% | -$78.2K | 0.38% | 47 |
|
|
2024
Q4 | $7.13M | Sell |
9,228
-25
| -0.3% | -$20.7K | 0.36% | 48 |
|
|
2024
Q3 | $8.2M | Sell |
9,253
-50
| -0.5% | -$45K | 0.4% | 45 |
|
|
2024
Q2 | $8.43M | Sell |
9,303
-86
| -0.9% | -$68.8K | 0.44% | 44 |
|
|
2024
Q1 | $7.31M | Sell |
9,389
-239
| -2% | -$170K | 0.39% | 47 |
|
|
2023
Q4 | $5.61M | Buy |
9,628
+292
| +3% | +$170K | 0.32% | 52 |
|
|
2023
Q3 | $5.02M | Buy |
9,336
+22
| +0.2% | +$11.3K | 0.31% | 51 |
|
|
2023
Q2 | $4.37M | Buy |
9,314
+147
| +2% | +$61.6K | 0.26% | 54 |
|
|
2023
Q1 | $3.15M | Sell |
9,167
-43
| -0.5% | -$14.5K | 0.2% | 71 |
|
|
2022
Q4 | $3.37M | Hold |
9,210
| – | – | 0.23% | 70 |
|
|
2022
Q3 | $2.98M | Sell |
9,210
-242
| -3% | -$76.7K | 0.21% | 66 |
|
|
2022
Q2 | $3.06M | Buy |
9,452
+75
| +0.8% | +$22.5K | 0.22% | 66 |
|
|
2022
Q1 | $2.69M | Buy |
9,377
+1,078
| +13% | +$277K | 0.17% | 75 |
|
|
2021
Q4 | $2.29M | Hold |
8,299
| – | – | 0.14% | 86 |
|
|
2021
Q3 | $1.91M | Hold |
8,299
| – | – | 0.13% | 91 |
|
|
2021
Q2 | $1.91M | Buy |
8,299
+12
| +0.1% | +$2.41K | 0.13% | 91 |
|
|
2021
Q1 | $1.55M | Sell |
8,287
-166
| -2% | -$32.5K | 0.11% | 99 |
|
|
2020
Q4 | $1.43M | Sell |
8,453
-857
| -9% | -$128K | 0.1% | 104 |
|
|
2020
Q3 | $1.38M | Buy |
9,310
+152
| +2% | +$23.5K | 0.11% | 104 |
|
|
2020
Q2 | $1.5M | Buy |
9,158
+306
| +3% | +$47K | 0.14% | 94 |
|
|
2020
Q1 | $1.23M | Buy |
8,852
+919
| +12% | +$126K | 0.13% | 91 |
|
|
2019
Q4 | $1.04M | Sell |
7,933
-80
| -1% | -$9.27K | 0.1% | 116 |
|
|
2019
Q3 | $896K | Buy |
8,013
+336
| +4% | +$37.4K | 0.09% | 116 |
|
|
2019
Q2 | $850K | Buy |
7,677
+400
| +5% | +$47.1K | 0.09% | 116 |
|
|
2019
Q1 | $944K | Buy |
7,277
+114
| +2% | +$13.9K | 0.1% | 109 |
|
|
2018
Q4 | $829K | Buy |
7,163
+3,916
| +121% | +$437K | 0.1% | 105 |
|
|
2018
Q3 | $348K | Hold |
3,247
| – | – | 0.04% | 197 |
|
|
2018
Q2 | $277K | Buy |
3,247
+1,627
| +100% | +$134K | 0.03% | 219 |
|
|
2018
Q1 | $125K | Sell |
1,620
-820
| -34% | -$66K | 0.02% | 357 |
|
|
2017
Q4 | $206K | Buy |
2,440
+885
| +57% | +$75.3K | 0.03% | 278 |
|
|
2017
Q3 | $133K | Hold |
1,555
| – | – | 0.02% | 349 |
|
|
2017
Q2 | $128K | Hold |
1,555
| – | – | 0.02% | 368 |
|
|
2017
Q1 | $131K | Hold |
1,555
| – | – | 0.02% | 358 |
|
|
2016
Q4 | $114K | Hold |
1,555
| – | – | 0.02% | 379 |
|
|
2016
Q3 | $125K | Hold |
1,555
| – | – | 0.02% | 355 |
|
|
2016
Q2 | $122K | Sell |
1,555
-1
| -0.1% | -$75 | 0.02% | 352 |
|
|
2016
Q1 | $112K | Buy |
1,556
+1,256
| +419% | +$95K | 0.02% | 363 |
|
|
2015
Q4 | $25K | Buy |
+300
| New | +$24.9K | 0.01% | 578 |
|
|
2014
Q1 | – | Sell |
-120
| Closed | -$6K | – | 846 |
|
|
2013
Q4 | $6K | Buy |
+120
| New | +$6.01K | ﹤0.01% | 747 |
|
Other funds holding LLY
VCM
VPM
Smithfield Trust's LLY Position: Q1 2026 in Review
Smithfield Trust increased its Eli Lilly (LLY) stake by 1.7% in Q1 2026, buying an estimated $161K and bringing the position to 9,591 shares worth $8.83M. The position accounts for 0.38% of the portfolio, ranked #49.
Smithfield Trust first reported a position in LLY in Q4 2013 and has held it in 43 quarters since. The position peaked at $10.1M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Smithfield Trust held 9,591 shares of Eli Lilly worth $8.83M as of Q1 2026.
- Smithfield Trust bought 159 Eli Lilly shares in Q1 2026, an estimated $161K.
- Eli Lilly made up 0.38% of Smithfield Trust's portfolio in Q1 2026, its #49 holding.
- Smithfield Trust first reported a position in Eli Lilly in Q4 2013 and has held it in 43 quarters since.
- Smithfield Trust's Eli Lilly position peaked at $10.1M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.